Back to Top
Rademikibart Biosimilar - Research Grade
$710.00 - $19,500.00
Rademikibart Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Species Reactivity
Human
Target
IL4R
Concentration
5mg/ml
Isotype
Human IgG4 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH2972
Uniprot
P24394
Shipping Conditions
Blue ice
Background
The interleukin-4 receptor (IL4R) is a shared signalling hub for IL-4 and IL-13 and a pivotal node in type 2 inflammation and allergic disease research. This anti-human IL4R recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of rademikibart, provided strictly for research use only. Produced to stringent in vivo standards with a low-endotoxin formulation, it is supplied in scalable milligram (mg) to gram (g) quantities to support bulk and high-throughput laboratories. Applications include receptor-blocking assays, in vitro functional screening, and in vivo models of allergic and inflammatory disease, where reproducibility matters.
Specificity
Detects human IL4R
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
4 weeks
Write Your Own Review














